Date: 2015-12-14
Type of information: Nomination
Compound:
Company: Intellia Therapeutics (USA - MA)
Therapeutic area: Technology - Services
Type agreement: nomination
Action mechanism:
Disease:
Details: * On December 14, 2015, Intellia Therapeutics has named Caroline Dorsa to its Board of Directors. Both as a director and business leader, Ms. Dorsa brings over 30 years of diverse experience and management in the public sector and regulated industries, including energy, pharmaceuticals and telecommunications. Ms. Dorsa has held a number of senior-management positions at Merck & Co., Inc., including Vice President and Treasurer where she also oversaw tax, financial planning for manufacturing and investor relations. Most recently, as Executive Vice President and CFO at Public Service Enterprise Group, Ms. Dorsa led the finance, business development and investor relations teams, delivering solid financial performance through a challenging period in the energy markets. She is a director of Biogen.
Financial terms:
Latest news:
